The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Omnicare beat slightly on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted slightly. Non-GAAP earnings per share grew significantly. GAAP earnings per share grew significantly.
Gross margins increased, operating margins contracted, net margins grew.
Omnicare tallied revenue of $1.53 billion. The eight analysts polled by S&P Capital IQ wanted to see a top line of $1.51 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.86. The eight earnings estimates compiled by S&P Capital IQ predicted $0.85 per share. Non-GAAP EPS of $0.86 for Q4 were 48% higher than the prior-year quarter's $0.58 per share. (The prior-year quarter included -$0.06 per share in earnings from discontinued operations.) GAAP EPS of $0.54 for Q4 were 100% higher than the prior-year quarter's $0.27 per share. (The prior-year quarter included -$0.06 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 24.6%, 150 basis points better than the prior-year quarter. Operating margin was 8.0%, 60 basis points worse than the prior-year quarter. Net margin was 3.9%, 190 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.55 billion. On the bottom line, the average EPS estimate is $0.86.
Next year's average estimate for revenue is $6.22 billion. The average EPS estimate is $3.53.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 224 members out of 245 rating the stock outperform, and 21 members rating it underperform. Among 89 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 86 give Omnicare a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Omnicare is outperform, with an average price target of $40.00.
Is Omnicare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Omnicare to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.